Teva Branded Pharmaceutical Products R&d Llc

This completed Phase 1 trial tested three different slow-release versions of the schizophrenia drug olanzapine in 106 adults with schizophrenia or schizoaffective disorder. The goal was to see how the body absorbs and processes each version compared to the standard immediate-rele…

This study tested a monthly injection called fremanezumab to prevent migraines in children and teens aged 6 to 17. Over 500 participants were followed for up to 84 months to check safety and how well the treatment works. The goal was to reduce the number of headache and migraine …

This study tested a new long-acting injectable form of olanzapine (TV-44749) for adults with schizophrenia. The goal was to see if it can control symptoms better than a placebo over 8 weeks. 675 participants took part, and the study also looked at safety and long-term effects up …

This study tested a new long-acting olanzapine injection (TV-44749) against the standard oral olanzapine pill in 153 people with schizophrenia. The goal was to see if the shot delivers similar drug levels and is safe. Participants received multiple doses over 21 weeks, with resea…

This study looked at how well and how safely deutetrabenazine works for Chinese adults with Huntington's disease who have chorea (uncontrolled movements). Fifty patients took the drug as part of their normal care. The main goal was to see if chorea scores improved, especially in …

This study tested different versions of the drug TEV-56286 (emrusolmin) in 47 healthy adults to see how well the body absorbs each form. Participants took a single dose of either a new formulation or a reference capsule, and researchers measured drug levels in the blood. The goal…